Adipokine-enriched brown adipocytes for treating polycystic ovary syndromes

富含脂肪因子的棕色脂肪细胞用于治疗多囊卵巢综合征

基本信息

  • 批准号:
    10546546
  • 负责人:
  • 金额:
    $ 25.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-19 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Abstract Polycystic ovary syndromes (PCOS) affect 6-18% of reproductive age female, representing the most common endocrine disease in this population. PCOS causes gynecological, dermatologic and metabolic comorbidities, and also imposes long-term risks of diabetes mellitus type 2 (T2D), cardiovascular diseases (CVD) and psychiatric problems including severe depression. PCOS is related to complex hormonal dysregulations such as hyperandrogenism, hyperinsulinemia and gonadotropin dysregulation. And PCOS is commonly associated with metabolic disorders, with 50-70% of PCOS patients showing insulin resistance and 10% with T2D, implying a potential causative interlinks between them. Current standard of care includes life style changes and multiple lines of medications with aims to relieve symptoms. Medications usually have moderate success rates, and have limited effects on long-term risks of T2D, CVD and psychiatric problems. We propose to use metabolically active brown adipocytes, which have high secretion of endocrine factors including but not limited to adiponectin, to treat PCOS. The working mechanisms may involve the both metabolic activities and endocrine secretions of brown adipocytes, which are previously extensively studied in metabolic programs and now indicative of clinical benefit for PCOS treatment as well. The present Phase I SBIR project aims to test the hypothesis based on our bank currently containing 150+ cell populations from donor, and evaluate clinically relevant efficacy of the selected cells in an established mouse model.
摘要 多囊卵巢综合征(PCOS)影响6-18%的育龄女性,是最常见的 内分泌疾病。多囊卵巢综合征引起妇科、皮肤病和代谢性共病, 并且还造成2型糖尿病(T2 D)、心血管疾病(CVD)和糖尿病并发症的长期风险。 精神问题包括严重的抑郁症。PCOS与复杂的激素失调有关, 高雄激素血症、高胰岛素血症和促性腺激素失调。多囊卵巢综合征通常与 代谢紊乱,50-70%的PCOS患者表现出胰岛素抵抗,10%患有T2 D,这意味着 它们之间潜在的因果联系。目前的护理标准包括生活方式的改变和多种 一系列旨在缓解症状的药物。药物治疗通常有中等的成功率, 对T2 D、CVD和精神问题的长期风险影响有限。我们建议使用代谢活跃的 棕色脂肪细胞,其具有高分泌的内分泌因子,包括但不限于脂联素,以治疗 PCOS。其作用机制可能与褐腐菌的代谢活动和内分泌活动有关 脂肪细胞,其先前在代谢程序中被广泛研究,并且现在指示临床益处 PCOS的治疗也是如此。目前的第一阶段SBIR项目旨在测试基于我们银行的假设 目前含有来自供体的150+细胞群,并评价所选细胞的临床相关疗效。 在已建立的小鼠模型中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yongxing Liu其他文献

Yongxing Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.66万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了